Mere Admixture or True Innovation? Crystal Crop’s Herbicidal Composition Fails the Synergy Test

A hand writing the word “SYNERGY” above the equation “1 + 1 > 2” in red marker, illustrating the concept that combined elements can produce a greater effect than their individual contributions. Featured image for article: Mere Admixture or True Innovation? Crystal Crop’s Herbicidal Composition Fails the Synergy Test

The Delhi High Court has reaffirmed a simple patent lesson: mixing known compounds will not do unless the mix delivers something unexpectedly better. In Crystal Crop, the claimed herbicidal composition failed that test.

Read more about Mere Admixture or True Innovation? Crystal Crop’s Herbicidal Composition Fails the Synergy Test

Examination and Pre-Grant Opposition Are Independent Proceedings; Composite Disposal Unsustainable

Bold text reading “NO SHORTCUTS,” with “NO” in red and “SHORTCUTS” in white, set against a dark background featuring Court Featured image for article: Examination and Pre-Grant Opposition Are Independent Proceedings; Composite Disposal Unsustainable

The Calcutta High Court has ruled that the Controller cannot collapse examination and pre-grant opposition into a single composite order to sidestep a Section 14 hearing. The decision reinforces natural justice and procedural discipline in Indian patent prosecution.

Read more about Examination and Pre-Grant Opposition Are Independent Proceedings; Composite Disposal Unsustainable

Can a Pre-Grant Opposition Survive After Patent Grant?

Text graphic with the phrase “Almost There!” in playful, rounded white font outlined in red, centered on a dark blue background. Featured image for article: Can a Pre-Grant Opposition Survive After Patent Grant?

The Delhi High Court confirmed that once a patent grant order is signed, a pre-grant opposition under Section 25(1) is no longer valid. This case involving Vertex Pharmaceuticals affirms that the signature date is definitive, regardless of later administrative delays.

Read more about Can a Pre-Grant Opposition Survive After Patent Grant?

Patent Examination and Pre-Grant Opposition are independent processes

The Delhi High Court has confirmed that patent examination and pre-grant opposition are independent processes under Indian law. Pre-grant opponents are entitled to participate only on specific grounds of opposition, not throughout the examination. This distinction ensures a balanced, efficient, and legally compliant patent process.

Read more about Patent Examination and Pre-Grant Opposition are independent processes

Delhi High Court asks the Patent Office to decide on amendments and give adequate opportunity in Opposition Proceedings

The Delhi High Court has provided clear procedural guidance for patent opposition proceedings, focusing on transparency and fair opportunity for all parties. The judgment underscores the importance of timely decisions on claim amendments and systematic handling of pre-grant oppositions by the Indian Patent Office.

Read more about Delhi High Court asks the Patent Office to decide on amendments and give adequate opportunity in Opposition Proceedings

High Court remands Patent Office’s Legally Infirm and Unreasoned Order

The Delhi High Court remanded a Patent Office order in a patent grant case for being legally infirm and unreasoned. The judgment underscores the importance of detailed reasoning and adherence to the principles of natural justice in patent proceedings.

Read more about High Court remands Patent Office’s Legally Infirm and Unreasoned Order

Delhi HC Interprets the Timeline for Pre-Grant Representation of a Patent

The Delhi High Court clarifies the timeline for pre-grant opposition under the Patents Act, distinguishing the rights of any person and a person interested. The judgment highlights legislative intent and the need for vigilance in patent opposition procedures.

Read more about Delhi HC Interprets the Timeline for Pre-Grant Representation of a Patent

Abbott’s HIV Drug Patent “Not an Invention”

The Indian Patent Office has rejected Abbott’s application for an HIV drug patent, finding no inventive step in the claimed composition. This decision highlights the robust scrutiny applied to pharmaceutical patents in India and the importance of pre grant opposition in safeguarding public health interests.

Read more about Abbott’s HIV Drug Patent “Not an Invention”